Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)

SHE:301246 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021
Cash & Equivalents	437.84	745.59	421.86	395.19	120.43	264.76
Short-Term Investments	-	-	292.31	90	-	-
Trading Asset Securities	1,183	900.32	1,466	-	-	3
Cash & Short-Term Investments	1,621	1,646	2,180	485.19	120.43	267.76
Cash Growth	-19.84%	-24.50%	349.31%	302.89%	-55.02%	35.06%
Accounts Receivable	624.07	559.44	602.64	660.21	458.16	308.66
Other Receivables	81.17	79.89	141.67	87.6	45.85	0.99
Receivables	705.24	639.33	744.3	747.8	504.01	309.65
Inventory	288.11	270.53	191.51	352.95	384.48	343.46
Other Current Assets	487.53	490.59	86.43	78.98	20.72	19.84
Total Current Assets	3,102	3,046	3,202	1,665	1,030	940.71
Property, Plant & Equipment	2,284	2,292	1,910	1,620	891.27	592.85
Long-Term Investments	198.63	203.64	228.08	335.12	242.35	97.24
Goodwill	-	-	-	-	-	6.5
Other Intangible Assets	182.28	181.89	183.06	173.62	194.15	84.12
Long-Term Deferred Tax Assets	18.88	17.26	17.56	21.22	17.72	14.54
Long-Term Deferred Charges	4.81	5.52	5.95	6.86	11.98	10.74
Other Long-Term Assets	83.3	78.06	103.9	53.27	45.14	13.82
Total Assets	5,874	5,825	5,651	3,875	2,432	1,761
Accounts Payable	756.15	777.27	636.79	934.95	340.92	155.08
Accrued Expenses	12.44	28.15	57.54	65.7	57.98	43.21
Short-Term Debt	168.06	59.32	-	17.64	20.1	149.26
Current Portion of Long-Term Debt	77.97	77.75	65.9	66.09	2.84	-
Current Portion of Leases	-	-	0.6	0.56	0.53	0.74
Current Income Taxes Payable	11.18	6.82	1.15	38.29	45.65	39.3
Current Unearned Revenue	18.22	13.87	19.8	31.01	29.66	13.93
Other Current Liabilities	140.21	172.81	133.04	165.66	120.05	100.93
Total Current Liabilities	1,184	1,136	914.83	1,320	617.73	502.45
Long-Term Debt	227.58	230.36	276.12	341.67	47.22	-
Long-Term Leases	6.82	7.16	6.9	8.19	8.23	8.12
Long-Term Unearned Revenue	75.41	68.64	71.55	70.45	60.8	44.79
Long-Term Deferred Tax Liabilities	22.14	21.62	21.54	21.31	20.3	20.9
Total Liabilities	1,516	1,464	1,291	1,762	754.27	576.27
Common Stock	400.01	400.01	400.01	352.75	352.75	352.75
Additional Paid-In Capital	2,173	2,172	2,172	22.15	20.62	20.62
Retained Earnings	1,827	1,818	1,786	1,739	1,304	810.3
Treasury Stock	-47.15	-32.8	-	-	-	-
Comprehensive Income & Other	4.96	3.37	1.89	0	0.46	0.57
Total Common Equity	4,357	4,361	4,360	2,114	1,678	1,184
Minority Interest	0.47	0.47	-	-	-	-
Shareholders' Equity	4,358	4,361	4,360	2,114	1,678	1,184
Total Liabilities & Equity	5,874	5,825	5,651	3,875	2,432	1,761
Total Debt	480.44	374.59	349.51	434.14	78.92	158.12
Net Cash (Debt)	1,140	1,271	1,831	51.05	41.51	109.64
Net Cash Growth	-31.94%	-30.55%	3485.91%	22.99%	-62.14%	-
Net Cash Per Share	2.87	3.19	4.72	0.14	0.12	0.31
Filing Date Shares Outstanding	396.7	397.82	399.9	400.01	352.75	346.7
Total Common Shares Outstanding	396.7	397.82	400.01	352.75	352.75	346.7
Working Capital	1,918	1,910	2,287	345.02	411.91	438.26
Book Value Per Share	10.98	10.96	10.90	5.99	4.76	3.42
Tangible Book Value	4,175	4,179	4,177	1,940	1,484	1,094
Tangible Book Value Per Share	10.52	10.50	10.44	5.50	4.21	3.15
Buildings	-	-	719.62	395.96	329.31	316.78
Machinery	-	-	1,470	782.58	657	567.68
Construction In Progress	-	-	375.86	946.39	334.11	67.57

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.